Food increases the bioavailability of mefloquine

European Journal of Clinical Pharmacology

Volumn 53, Issue 2, 1997, Pages 135-139

  Crevoisier, C ^a   Handschin, J ^a   Barre J ^b   Roumenov, D ^b   Kleinbloesem, C ^c  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c Clin Pharma Research AG   (Switzerland)

Author keywords

Bioavailability; Food interaction; Mefloquine

Indexed keywords

ANTIMALARIAL AGENT; DRUG METABOLITE; MEFLOQUINE;

ADULT; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FOOD DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; SMOKING; TABLET; VERTIGO;

ADMINISTRATION, ORAL; ADULT; ANTIMALARIALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FOOD; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION; MALE; MEFLOQUINE;

EID: 0030828677     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050351     Document Type: Article

References (17)

1. Karbwang J, White J (1990) Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 19: 264-279
2. White NJ (1988) Drug treatment and prevention of malaria. Eur J Clin Pharmacol 34: 1-14
3. Franssen G, Rouveix B, Lebras J, Bauchet J, Verdier F, Michon C, Bricaire F (1989) Divided-dose kinetics of mefloquine in man. Br J Clin Pharmacol 28: 179-184
4. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC (1993) Long-term malaria prophylaxis with weekly mefloquine. Lancet 341: 848-851
5. Lobel HO, Bernard KW, Williams SL, Hightower AW, Patchen LC, Campbell CC (1991) Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine: need for a better dosing regimen. JAMA 265: 361-364
6. Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L (1993) Tolerability of prophylactic Lariam ® regimens. Trop Med Parasitol 44: 257-265
7. Welling PG (1984) Interactions affecting drug absorption. Clin Pharmacokinet 9: 404-434
8. Tulpule A, Krishnaswamy K (1982) Effect of food on bioavailability of chloroquine. Eur J Clin Pharmacol 23: 271-273
9. Milton KA, Edwards G, Ward SA, Orme MLE, Breckenridge AM (1989) Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol 28: 71-77
10. Rolan PE, Mercer AJ, Weatherley BC, Meire TH, Peck RW, Ridout G, Posner J (1994) Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol 37: 13-20
11. Bergqvist Y (1988) High-performance liquid Chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr 432: 253-263
12. Looareesuwan S, White NJ, Warrell DA, Forgo I, Dubach UG, Ranalder UB, Schwartz DE (1987) Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol 24: 37-42
13. Desjardins RE, Pamplin III CL, von Bredow J, Barry KG, Canfield CJ (1979) Kinetics of a new antimalarial, mefloquine. Clin Pharmacol Ther 26: 372-379
14. Fontanet AL, Johnston BD, Walker AM, Bergqvist Y, Hellgren U, Rooney W (1994) Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine. Bull World Health Organ 72: 73-78
15. Ter Kuile FO (1994) Mefloquine, halofantrine and artesunate in the treatment of uncomplicated falciparum malaria in a multi-drug resistant area. Thesis. University of Amsterdam. The Netherlands
16. Schlagenhauf P, Steffen R, Lobel H, Johnson R, Letz R, Tschopp A, Vranjes N, Bergqvist Y, Ericsson O, Hellgren U, Rombo L, Mannino S, Handschin J, Stürchler D (1996) Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health 1: 485-494
17. World Health Organization (1991) Review of central nervous system adverse events related to the antimalarial drug mefloquine (1985-1990). World Health Organ MAL 91: 1063